期刊文献+

人类免疫缺陷病毒-1整合酶抑制剂的研究进展 被引量:5

Research Progress in HIV-1 Integrase Inhibitors
原文传递
导出
摘要 目的对人类免疫缺陷病毒-1整合酶抑制剂的最新研究情况进行综述。方法根据国内外文献报道,对已上市的3种人类免疫缺陷病毒-1整合酶抑制剂药物和新作用机制的整合酶抑制剂的研究情况进行归纳总结。结果与结论整合酶是人类免疫缺陷病毒-1病毒复制周期必需的基本酶之一,是新型抗艾滋病药物的作用靶点。随着人类免疫缺陷病毒耐药现象变得严重,整合酶抑制剂作为新作用机制的艾滋病治疗药物为临床提供了新的选择,新靶点和多靶点整合酶抑制剂的研发也使得未来人类免疫缺陷病毒治疗有更好的前景。 OBJECTIVE To review the latest research progress in HIV-1 integrase inhibitors.METHODS The research progress of the three marketed integrase inhibitor drugs and the integrase inhibitors with new mechanism were summarized according to the related articles.RESULTS AND CONCLUSION HIV-1 integrase as a novel target of new anti-AIDS drugs is one of the most essential enzymes for viral replication cycle.With the drug resistance of HIV becoming serious,integrase inhibitors as the new anti-AIDS drugs which have new mechanism of action can provide more choices to clinic.The research and development of integrase inhibitors with novel target and multiple targets have better prospect in the treatment of HIV.
出处 《中国药学杂志》 CAS CSCD 北大核心 2014年第21期1877-1881,共5页 Chinese Pharmaceutical Journal
关键词 人类免疫缺陷病毒-1整合酶抑制剂 耐药 作用机制 研究进展 HIV-1 integrase inhibitor resistance action mechanism research progress
  • 相关文献

参考文献43

  • 1WHO. HIV/AIDS[EB/OL]. (2013-10-30)[2014-4-15]. http://www.who.int/mediacentre/factsheets/fs360/en/.
  • 2WHO. HIV/AIDS[EB/OL]. (2013-10-30)[2014-4-15]. http://www.who.int/features/qa/71/en/.
  • 3POMMIER Y, JOHNSON A A, MARCHAND C. Integrase inhibitors to treat HIV/AIDS[J]. Nat Rev Drug Discov, 2005, 4(3): 236-248.
  • 4WILKINSON T A, JANUSZYK K, PHILLIPS M L, et al. Identifying and characterizing a functional HIV-1 reverse transcriptase-binding site on integrase[J]. J Biol Chem, 2009, 284(12): 7931-7939.
  • 5DOBARD C W, BRIONES M S, CHOW S A. Molecular mechanisms by which human immunodeficiency virus type 1 integrase stimulates the early steps of reverse transcription[J]. J Virol, 2007, 81(18): 10037-10046.
  • 6LU R, GHORY H Z, ENGELMAN A. Genetic analyses of conserved residues in the carboxyl-terminal domain of human immunodeficiency virus type 1 integrase[J]. J Virol, 2005, 79(16): 10356-10368.
  • 7HAZUDA D J, YOUNG S D, GUARE J P, et al. Integrase inhibitors and cellular immunity suppress retroviral replication in rhesus macaques[J]. Science, 2004, 305(5683): 528-532.
  • 8HARE S, GUPTA S S, VALKOV E, et al. Retroviral intasome assembly and inhibition of DNA strand transfer[J]. Nature, 2010, 464(7286): 232-236.
  • 9COCOHOBA J, DONG B J. Raltegravir: The first HIV integrase inhibitor[J]. Clin Ther, 2008, 30(10): 1747-1765.
  • 10FDA expands use of HIV drug Isentress to children and adolescents [EB/OL]. (2011-12-21)[2014-4-28]. http://www.fda.gov/newsevents/newsroom/pressannouncements/ucm284473.htm.

同被引文献33

引证文献5

二级引证文献13

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部